The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 04, 2024
Filed:
May. 24, 2019
Applicant:
Roche Diabetes Care, Inc., Indianapolis, IN (US);
Inventor:
Christian Ringemann, Mannheim, DE;
Assignee:
Roche Diabetes Care, Inc., Indianapolis, IN (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/11 (2006.01); A61M 5/172 (2006.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
A61B 5/14532 (2013.01); A61B 5/0205 (2013.01); A61B 5/1118 (2013.01); A61B 5/7264 (2013.01); A61B 5/742 (2013.01); A61M 5/1723 (2013.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); A61B 5/0093 (2013.01); A61B 5/1112 (2013.01); A61B 5/14546 (2013.01); A61B 5/4839 (2013.01); A61B 5/6801 (2013.01); A61M 2230/201 (2013.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01);
Abstract
The disclosure relates to a method and system for controlling glucose levels comprising receiving behavioral sensor measurements and analyte sensor measurements, determining a plurality of analyte profiles from continuous analyte sensor measurements; grouping the plurality of analyte profiles into clusters; assigning a selected behavioral parameter or a selected pattern of behavioral parameters to each analyte profile in a first cluster, and providing a treatment recommendation.